Skip to Content
Capgemini_Solution_Decentralized-clinical-trials
Solution

INTELLIGENT AND DECENTRALIZED CLINICAL TRIALS

The Clinical Trial of the Future – report3 MB pdf
Download infographic824 KB pdf

Decentralized clinical trials are here – and the possibilities are everywhere. The ability to monitor participants of clinical trials at home in real-time is opening up a world of potential benefits.

Fully remote or hybrid trials are enabled by a combination of digital technologies and at-home services that open the door to a new chapter in clinical trials.

How we can help

Capgemini is uniquely positioned to support your adoption of DCTs, providing lift across five dimensions:

Connected Health Mastery – end-to-end experience designing and developing services and digital products for trial monitoring

Human-centered Design – inspired by patient and HCP experience, and our insights from ethnography, applied data, and behavioral science

Platform Plug-and-Play Experiences – experienced in designing, building and operating your DCT platform

Change Management – supports Clinical Operations transformation to align stakeholders on the changes that DCT introduces

Data Engineering and Science Expertise – proven expertise in setting up health data models, data engineering and data science for clinical trials platforms.

Accelerate time to care, improve data quality, reduce costs

Decentralized clinical trials (DCTs) can help you as follows:

Accelerate time to care – as patient-centric approach maximizes participation and retention

Improve data quality – as automated data gathering reduces risk of error

Reduce overall trial costs – as efficient framework streamlines enrollment, engagement and trial management.

Team up with us

Life sciences companies are just beginning to explore this new stage in clinical trials.

Team up with an experienced partner and take the lead on DCTs.

Meet our experts

Barnabé Lecouteux

Senior Director, Data & Analytics for Intelligent Industry, Capgemini Invent
Barnabé Lecouteux has 14 years of experience leading strategic and operational projects, with a focus on Data and Artificial Intelligence (AI) topics in the life sciences. He started his career as a consultant for Capgemini on operations transformation in the services, industry and life sciences sectors. Barnabé has a total of 8 years of experience in life sciences, first at Ipsen Pharma as Director of Strategic Planning and then at Air Liquide Healthcare, where he held the positions of Head of Chronic Renal Disease BU and Director of Digital Strategy for chronic diseases.

David Ghesquieres

Life Sciences Strategy & Business Development Director